AnswerThisView only
Shared answer · view only
AShared by Ayush · Sep 24
LoginSign up
Health/A young woman with fatigue, jaundice, and positive anti-smooth muscle antibodies likely has
A young woman with fatigue, jaundice, and positive anti-smooth muscle antibodies likely has ? A. Wilson's Disease B. Autoimmune Hepatitis C. Primary Biliary Cholangitis D. Acute Viral Hepatitis
Used tools Searching academic papers for anti-smooth muscle antibodies fatigue jaundice young woman autoimmune hepatitis, found 119 papers

A young woman presenting with fatigue, jaundice, and positive anti-smooth muscle antibodies (ASMA) most likely has Autoimmune Hepatitis (AIH) (choice B).

Diagnostic Reasoning

Autoimmune hepatitis is a chronic inflammatory liver disease that predominantly affects females and can present at any age, but often in young to middle-aged women. The clinical presentation commonly includes nonspecific symptoms such as fatigue and jaundice, and laboratory markers often indicate hepatocellular injury (elevated transaminases) and the presence of autoantibodies—most notably, positive anti-smooth muscle antibodies and/or antinuclear antibodies. Elevated serum immunoglobulin G (IgG) is also typical, though not required for diagnosis(Aljumah, 2019).

  • Positive anti-smooth muscle antibodies are highly specific for type 1 autoimmune hepatitis, especially in combination with fatigue and jaundice(Manns, 2010).
  • Up to 69% of patients with acute AIH will have ASMA positivity(Aljumah, 2019), and these findings help differentiate AIH from other liver conditions.

Excluding Other Diagnoses

Wilson’s Disease (A)

  • Wilson's disease can present with hepatic, neurologic, and psychiatric symptoms in young individuals, but it is characterized by low ceruloplasmin, Kayser-Fleischer rings, and not by positive ASMA(Manns, 2010).
  • Wilson's disease can cause jaundice and fatigue, but ASMA is not a diagnostic marker.

Primary Biliary Cholangitis (C)

  • Primary biliary cholangitis (PBC) is characterized by cholestatic injury and the signature pattern is antimitochondrial antibody (AMA) positivity, not ASMA(Purohit, 2015).
  • While up to 10% of PBC patients can lack AMA, the classic presentation is middle-aged women, pruritus, and evidence of chronic cholestasis(Louie, 2020).
  • PBC-AIH overlap can show both ASMA and AMA, but the isolated presence of ASMA is more supportive of 'classic' AIH(Purohit, 2015).

Acute Viral Hepatitis (D)

  • Acute viral hepatitis can also present with jaundice and fatigue but is typically diagnosed by viral serologies, not autoantibody markers such as ASMA(Manns, 2010).
  • While mild autoantibody positivity can be seen in viral hepatitis, high-titer ASMA and compatible clinical syndrome point much more strongly to AIH(Prifti-Kurti, 2023).

Supporting Academic Evidence

  • AIH frequently presents in young women with fatigue and jaundice, and diagnosis is supported by ASMA positivity, elevated aminotransferases, and biopsy findings(Sultan, 2011)(Aljumah, 2019).
  • ASMA is more specific for type 1 AIH compared to other liver diseases, as confirmed by multiple studies evaluating diagnostic accuracies and clinical cohorts(Prifti-Kurti, 2023)(Uyar, 2023).
  • The diagnostic value of ASMA (especially at higher titers) in the clinical context of hepatitis is well-established across global and guideline-based literature(Manns, 2010)(Aljumah, 2019)(Patel, 2025).

Clinical Pearls

  • Women are affected 3-4 times more often than men(Blashinsky, 2024).
  • AIH can also present with extrahepatic autoimmune disorders, such as thyroid disease or joint symptoms(Blashinsky, 2024).
  • The course may be acute, but more frequently, it is insidious and chronic(Manns, 2010).

Summary Table

ConditionFatigueJaundicePositive ASMAOther FeaturesMost Likely?
Autoimmune Hepatitis (AIH)YesYesYesWomen > men; ↑IgG; ANA may also be +Yes
Wilson’s DiseaseYesYesRareLow ceruloplasmin, neurologic featuresNo
Primary Biliary CholangitisOftenSometimesRare/possiblePruritus, AMA+ in most, cholestasis labsNo
Acute Viral HepatitisYesYesRare/low-titerRecent infection, positive viral markersNo

Conclusion

The most likely diagnosis for a young woman with fatigue, jaundice, and positive anti-smooth muscle antibodies is Autoimmune Hepatitis(Aljumah, 2019)(Manns, 2010)(Sultan, 2011)(Patel, 2025)(Blashinsky, 2024)(Prifti-Kurti, 2023)(Uyar, 2023)(Podgrska, 2024)(Algraittee, 2021)(Zhang, 2014)(Tyndall, 2024)(Mohamed, 2024)(Engel, 2024)(Uyar, 2023)(Coy, 2019)(Coy, 2019)(Balassiano, 2023)(Patel, 2025)(Rahman, 2022)(Liu, 2022)(Rana, 2022)(Alqrinawi, 2019).

Would you like more details on the diagnostic process for autoimmune hepatitis, or information on its management and prognosis?

Save

Citation Lists

A. Coy, Pedro Snchez, W. Rojas, D. Hernndez · 2019-04-15 · Journal of the Endocrine Society

Satar Jabbar Rahi Algraittee · 2021-12-31 · JOURNAL OF COMMUNICABLE DISEASES

Tzu-Yu Liu, Thomas Sepe · 2022-10-01 · Lippincott Williams & Wilkins

Suggested next steps

Run a sensitivity analysisTurn this into a reportAnalyze an uploaded PDFEdit the draftExport the extraction table
TRY:
History

Loading sources…

Q1

A young woman with fatigue, jaundice, and positive anti-smooth muscle antibodies likely has ? A. Wilson's Disease B. Autoimmune Hepatitis C. Primary Biliary Cholangitis D. Acute Viral Hepatitis

Abstract
Source 1: SAT-582 Autoimmune Hepatitis Presenting with Graves Disease

A. Coy, Pedro Snchez, +2 · 2019 · Journal of the Endocrine Society · 1 citations

10.1210/JS.2019-SAT-582

Abstract Graves disease, the most common cause of hyperthyroidism in the world has an incidence peak between 30 and 50 years of age. It is more frequent in women that in men with a ratio of 5:1. The typical presentation is thyrotoxicosis, goiter and opthalmopathy. The most specific laboratory finding is the activating autoantibodies directed against the thyrotropin receptor, present in up to 98% o…

Source 2: Autoimmune Hepatitis: Evaluation of Clinical Presentation, Diagnosis and Response to Treatment in Iraqi Patients

Satar Jabbar Rahi Algraittee · 2021 · JOURNAL OF COMMUNICABLE DISEASES

10.24321/0019.5138.202180

Introduction: Autoimmune hepatitis (AIH) is a chronic heterogeneous inflammatory disease of the liver activated by unknown triggers. The details of its pathogenesis remain unclear. Sufficient data on AIH in terms of epidemiology as well as disease phenotype amongst the Iraqi population is not available. Objectives: To evaluate and document the experience of Iraqi AIH patients with respect to clini…

Source 3: S2918 Autoimmune Hepatitis-Like Syndrome After Coronavirus Disease 2019 Vaccine

Tzu-Yu Liu, Thomas Sepe · 2022 · Lippincott Williams & Wilkins · 1 citations

10.14309/01.ajg.0000868312.84652.96

Introduction: The coronavirus disease 2019 (COVID-19) pandemic has brought a wave of devastation, resulting in six million deaths worldwide. This prompted the rapid development anti-COVID vaccines: mRNA vaccines BNTb262 and mRNA-1273. A wide range autoimmune diseases are increasingly being reported following COVID-19 vaccination. We describe rare case hepatitis-like syndrome mRNA-1273 SARS-CoV-2 C…

Source 4: Meta-Analysis: Diagnostic Accuracy of Antinuclear Antibodies, Smooth Muscle Antibodies and Antibodies to a Soluble Liver Antigen/Liver Pancreas in Autoimmune Hepatitis

Wen-chao Zhang, Fengrong Zhao, +2 · 2014 · PLoS ONE · 40 citations

10.1371/journal.pone.0092267

Background Antinuclear antibodies (ANA), smooth muscle antibodies (SMA) and antibodies to a soluble liver antigen/liver pancreas (anti-SLA/LP) are useful markers that can help clinicians to diagnose and classify autoimmune hepatitis (AIH). Objectives To determine whether ANA, SMA and anti-SLA/LP help to accurately diagnose patients with AIH. Search strategy The PubMed, CNKI, WANFANG, and SinoMed d…

Source 5: Acute onset autoimmune hepatitis: Clinical presentation and treatment outcomes

Abdulrahman Aljumah, Hamad Al-Ashgar, +2 · 2019 · Elsevier BV · 26 citations

10.1016/j.aohep.2018.09.001

Autoimmune hepatitis (AIH) may present acutely, which can rapidly progress to fulminant type. This pattern has been described worldwide but is generally under-reported. We aim describe the clinical presentation and treatment outcomes of patients with acute onset AIH.A multicenter retrospective cohort study AIH. Clinical, biochemical, histological data were analyzed reported.Seventy included. The m…

Source 6: Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy

Treta Purohit · 2015 · Baishideng Publishing Group · 109 citations

10.4254/wjh.v7.i7.926

Primary biliary cirrhosis (PBC) is an autoimmune, slowly progressive, cholestatic, liver disease characterized by a triad of chronic cholestasis, circulating anti-mitochondrial antibodies (AMA), and characteristic biopsy findings nonsuppurative destructive cholangitis interlobular bile duct destruction.About 10% PBC patients, however, lack AMA.A variant, called PBC-autoimmune hepatitis (AIH) overl…

Source 7: CASE REPORT: AUTOIMMUNE HEPATITIS IN A 29-YEAR-OLD FEMALE WITH RECURRENT PREGNANCY LOSS

Mohamed Mahmoud Ibrahim Mohamed, Hesham Fawzy Kewan, +7 · 2024 · International Journal of Advanced Research

10.21474/ijar01/19696

Autoimmune hepatitis (AIH) is a rare chronic liver disease characterized by a wide spectrum of symptoms ranging from asymptomatic to jaundice, which can be confusing in diagnosis because of their non-specificity and the presence of laboratory changes. This case report presents a 29-year-old woman with AIH and past history of repetitive pregnancy losses. She has been diagnosed with various problems…

Source 8: Autoimmune hepatitis as a rare cause of cirrhosis development

Dominika Podgrska, Karolina Jurasz, +6 · 2024 · Journal of Education, Health and Sport

10.12775/jehs.2024.56.009

Cirrhosis is a serious condition associated with progressive damage to this organ. Autoimmune hepatitis (AIH) is one of the causes leading to the development of cirrhosis. This disease is characterized by chronic inflammation with damage to hepatocytes and presence of specific immune markers. The diagnosis of AIH is based on biochemical, immunoserological and histopathological tests. There are def…

Source 9: The Diagnostic Value of ANA and Anti-SMA in Suspected Patients with Autoimmune Hepatitis

Margarita Prifti-Kurti, G. Sulcebe, +1 · 2023 · South East European Journal of Immunology

10.3889/seejim.2023.6056

Abstract BACKGROUND Autoimmune hepatitis (AIH) is an unknown chronic disease characterized by hepatocellular inflammation with a tendency to progress to cirrhosis. AIH can present with symptoms of acute hepatitis with symptoms of chronic liver disease. AIH occurs globally; it is more commonly found in females. Autoantibodies such as antinuclear, smooth muscle, liver kidney microsome, and soluble l…

Source 10: S2923 De Novo Autoimmune Hepatitis Following COVID Vaccination: A Case Series

Fariba Rana, Shannon Todd, +3 · 2022 · Lippincott Williams & Wilkins · 1 citations

10.14309/01.ajg.0000868332.74154.4b

Introduction: We present a case series of patients with de novo autoimmune hepatitis following COVID vaccination. Case Description/Methods: A 68-year-old female past medical history GERD and diverticulitis presents the sudden onset dark urine three days after receiving second Moderna vaccine. This is followed by right upper quadrant pain, jaundice, nausea, vomiting, acholic stools. She denies any…

21 sources · 0 selected
1 / 3